首页> 外文会议>International Conference on Frontiers of Biological Sciences and Engineering >Correlation of the MMP-9 and Inhibitor-1, TNF-A and Bone Mineral Density in Patients with Chronic Obstructive Pulmonary Disease
【24h】

Correlation of the MMP-9 and Inhibitor-1, TNF-A and Bone Mineral Density in Patients with Chronic Obstructive Pulmonary Disease

机译:慢性阻塞性肺疾病患者MMP-9和抑制剂-1,TNF-A和骨密度的相关性

获取原文

摘要

Objective: to explore the Correlation of the Matrix Metallo Preteinases-9 (MMP-9) and inhibitor-1, TNF-a and bone mineral density in the chronic obstructive pulmonary disease (COPD) patients. Methods: 90 male patients diagnosed with COPD at the stable period were selected in this study got their BMD examined by dual energy X-ray absorptiometry (DXA). According to the results of the BMD, they were dived into normal group, low bone mass group and osteoporosis group each with 30 cases. Before the selection, we should record the history, pulmonary function, severity of the illness (CAT scores), and examined the MMP-9, TIMP-1, TNF-a and serum bone alkaline phosphatase (sBAP), serum osteocalcin (sOC), serum I type Collagen cross linked C terminal peptide (sCTX). Results: During the stage period, the BMI, CAT scores of the osteoporosis group, normal group and low bone mass group were significantly different from each other (all P<0.01); but the difference in the age, smoking indexes, FEV1/FVC, FEV1 % Pre was not statistically significant (P>0.05). The BMD in the lumbar vertebrae and neck of femur in the L group and O group were respectively lower compared with the normal group (P<0.05; P<0.01). Serum level of MMP-9, ratio of MMP-9/TIMP-1, TNF-a steppedly increased in the normal group, L and O group, especial the O group (P<0.05; P<0.01). Serum level of TIMP-1 stepdly increased in the normal group, L and O group, but it did not significantly (P>0.05). The sBAP, sOC in the L and O group were lower than the normal group (P<0.01), without statistical significance (P>0.05). The sCTX in the O group, was significantly higher than the normal group and L group, (P<0.01), but the different between the L group and N group were not statistically significant (P>0.05). The BMI in the lumbar vertebra and neck of the furmur, FEV1% Pre and MMP-9 were significantly negative correlative (respectively r=-0.432, P<0.01; r=-0.697 P<0.01; r=-0.226, P<0.05); the BMI in the lumbar vertebra and nec
机译:目的:探讨慢性阻塞性肺疾病(COPD)患者的基质金属素Preteinase-9(MMP-9)和抑制剂-1,TNF-A和骨密度的相关性。方法:在该研究中选择了90例患有COPD的男性患者,并通过双能X射线吸收测定法(DXA)检查其BMD。根据BMD的结果,它们分为正常组,低骨质群和骨质疏松症组,每次含30例。在选择之前,我们应该记录历史,肺功能,疾病的严重程度(CAT分数),并检查MMP-9,TIMP-1,TNF-A和血清碱性磷酸酶(SBAP),血清骨钙素(SOC) ,血清I型胶原蛋白交联C末端肽(SCTX)。结果:在舞台期间,BMI,骨质疏松症组,正常组和低骨质量组的BMI,彼此显着不同(所有P <0.01);但是,年龄差异,吸烟指数,FEV1 / FVC,FEV1%前的PE统计学意义(P> 0.05)。与正常组相比,L组和O组患者腰椎和股骨颈中的BMD分别较低(P <0.05; P <0.01)。 MMP-9的血清水平,MMP-9 / TIMP-1的比例,TNF-A在正常组,L和O组中逐渐增加,特别是O组(P <0.05; P <0.01)。在正常组,L和O组中血清TIMP-1步骤水平,但它没有显着(p> 0.05)。 L和O组中的SBAP,SOC低于正常组(P <0.01),无统计学意义(P> 0.05)。 O组中的SCTX显着高于正常组和L组,(P <0.01),但L组和N组之间的不同差异(P> 0.05)。 FEV1%前和MMP-9的腰椎和MMP-9中的腰椎和颈部的BMI显着负相关性(分别r = -0.432,P <0.01; r = -0.697 p <0.01; r = -0.226,p <0.05 );腰椎的BMI和NEC

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号